Marketer to pay $3.3M for compound prescription scheme
Prosecutors in Indiana announced Wednesday that a medical marketer from California was ordered to pay $3.3 million in restitution after pleading guilty to paying kickbacks to physicians who prescribed compound drugs to injured federal workers.
Manuel J. Bojorquez of Anaheim, California, was also sentenced to serve 18 months of home confinement followed by 36 months of probation.
Mr. Bojorquez owned and operated MD Medical Distribution, which operated as DynaMD. From 2013 through 2016, he acted as a marketer for several compounding pharmacies in Indiana.
“Bojorquez used his marketing company to funnel millions of dollars to Chicago-based physicians, in exchange for their referral of prescriptions to the Indiana-based pharmacies,” the Department of Justice said in a statement. “Bojorquez and his company received a percentage of the money paid for those kickback-induced prescriptions.”
Prosecutors said the U.S. Department of Labor’s Office of Workers’ Compensation Programs paid more than $8 million for prescriptions Mr. Bojorquez induced by paying kickbacks.
WorkCompCentral is a sister publication of Business Insurance. More stories here.
Read Next
-
Pandemic compounds retirement plan challenges
An Organization for Economic Co-operation and Development report states that the COVID-19 pandemic has compounded the challenges facing retirement savings and pension arrangements, Pensions Age Magazine reported. According to the report titled ‘OECD Pensions Outlook 2020’, pressures that existed before the pandemic such as ageing populations, low growth, low returns and low-interest rates will continue “long into the future” as a result of the pandemic.
Related Stories
Most Read in Workers Comp
-
1. Zurich ordered to pay $80 million in suit over employee incentives
-
3. Marsh McLennan sees rate hikes slowing; reports revenue growth
-
4. Travelers sees rate hikes continue; Q1 profit up over 15%
-
5. DeSantis signs legislation prohibiting local workplace heat protections
-
6. AI not a ‘substitute,’ but can benefit insurance industry: Experts
